Viviane Monaco-Dettmer
Freiburg, BW 79106, Germany
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 9 publications
Genotoxicity profiling reveals distinct platform-and cell type-specific effects in therapeutic gene editing for genetic hyperinflammation.
Journal: Cell stem cell
Published: August 19, 2025
Correction: Patients and mice with deficiency in the SNARE protein SYNTAXIN-11 have a secondary B cell defect.
Journal: The Journal of experimental medicine
Published: May 21, 2024
Gene editing of hematopoietic stem cells restores T-cell response in familial hemophagocytic lymphohistiocytosis.
Journal: The Journal of allergy and clinical immunology
Published: May 07, 2023
Enhanced cytotoxicity of a Pseudomonas Exotoxin A based immunotoxin against prostate cancer by addition of the endosomal escape enhancer SO1861.
Journal: Frontiers in pharmacology
Published: April 25, 2023
Transcriptomic Landscape and Functional Characterization of Human Induced Pluripotent Stem Cell-Derived Limbal Epithelial Progenitor Cells.
Journal: Cells
Published: October 07, 2022
Patients and mice with deficiency in the SNARE protein SYNTAXIN-11 have a secondary B cell defect.
Journal: The Journal of experimental medicine
Published: June 30, 2022
Adoptive T cell therapy cures mice from active hemophagocytic lymphohistiocytosis (HLH).
Journal: EMBO molecular medicine
Published: April 05, 2022
PSMA-Directed CAR T Cells Combined with Low-Dose Docetaxel Treatment Induce Tumor Regression in a Prostate Cancer Xenograft Model.
Journal: Molecular therapy oncolytics
Published: March 04, 2020
Showing 1-9 of 9
Last Updated: 09/26/2026